SCHEMBL7236291

SCHEMBL7236291

CCc1cc(-c2cccnc2)n[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.72
CYP2C19 P33261 4/20 0.72
CYP2C9 P11712 3/20 0.72
CYP2B6 P20813 3/20 0.72
CYP2D6 P10635 1/20 0.72
ALK Q9UM73 1/20 0.69
CYP3A4 P08684 3/20 0.63
CYP1A2 P05177 3/20 0.63
ALDH1A1 P00352 3/20 0.63
CYP2E1 P05181 2/20 0.49
TDP1 Q9NUW8 1/20 0.48
METAP2 P50579 1/20 0.47
SIRT3 Q9NTG7 1/20 0.47
PIM1 P11309 4/20 0.47
PIM3 Q86V86 2/20 0.47
PIM2 Q9P1W9 2/20 0.47
HPGDS O60760 1/20 0.47
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
HDAC3 O15379 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23546380 0.84 CYP2A6 (0.68) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL3608558 0.84 CYP2A6 (1.00) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL28154455 0.84 CYP2A6 (0.72) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL1436058 0.81 ALK (1.00) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL27904997 0.81 CYP2D6 (0.68) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL1696565 0.81 L3MBTL1 (0.63) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL5103972 0.80 CYP2D6 (0.67) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL22191641 0.80 CYP2D6 (0.67) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
SCHEMBL22191575 0.80 ALK (0.58) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6
Hydrochloric Acid SCHEMBL22320090 0.79 CYP2D6 (0.65) CYP2A6CYP2C19CYP2C9CYP2B6CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506747-B1 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-01-14 US disclosed
WO-1999062885-A1 SUBSTITUTED 1-(4-AMINOPHENYL)PYRAZOLES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-12-09 WO disclosed